Toxicity study of a rubber antioxidant, 2-mercaptobenzimidazole, by repeated oral administration to rats

Journal of Toxicological Sciences

Volumn 23, Issue 1, 1998, Pages 53-68

  Kawasaki, Yasushi ^a   Umemura, Takashi ^a   Saito, Minoru ^a   Momma, Junko ^a   Matsushima, Yuko ^a   Sekiguchi, Hiromi ^a   Matsumoto, Mami ^a   Sakemi, Kazue ^a   Isama, Kazuo ^a   Inoue, Tohru ^a   Kurokawa, Yuji ^a   Tsuda, Mitsuhiro ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

2 mercaptobenzimidazole; Gavage administration; Rats; Rubber antioxidant; Thymus involution; Thyroid toxicity

Indexed keywords

2 BENZIMIDAZOLETHIOL DERIVATIVE; 2 IMIDAZOLIDINETHIONE; LIOTHYRONINE; THIOUREA; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; INTOXICATION; LEUKOPENIA; MALE; NONHUMAN; RAT; THYROID HYPERPLASIA; THYROID WEIGHT; TOXICITY TESTING; WEIGHT REDUCTION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031935692     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.23.53     Document Type: Article

References (23)

1. Airaudo, C. B., Gayte-Sorbier, A, Momburg, R. and Laurent, P. (1990): Leaching of antioxidants and vulcanization accelerators from rubber closures into drug preparations. J. Biomater. Sci. Polym. Ed., 1, 231-241.
2. Asano, Y. (1982): Sodium, Potassium Metabolism and Thyroid Hormones. In Water, Electrolytes and Hormones (in Japanese), Eds, Koshikawa, S., Fujita, T., and Shimizu, N., Ishiyaku Shuppan Ltd. Tokyo, Japan
3. Barilyak, I. R. (1974): Embryotoxic and mutagenic effects of 2-mercaptobenzimidazole. Fiziol. Akt. Veshchestva 6, 85-88.
4. Barilyak. I. R. and Melnik, E. K. (1979): Dynamics of the cytogenetic effect of some chemical preparations. Dopov. Akad. Nauk Ukr. RSR Ser. B. 1, 66-69.
5. Deorge, D. R. (1986): Mechanism-based inhibition of lactoperoxidase by thiocarbamide goitrogens. Biochemistry, 25, 4724-4728.
6. El Dareer, S. M., Kalin, J. K., Tillery, K. F. and Hill, D. L. (1984): Disposition of 2-mercaptobenzimida-zole in rats dosed orally or intravenously. J. Toxicol. Environ. Health., 14, 595-604.
7. Fujita, T. (1987): Parathyroid Diseases. In Handbook of Clinical Pharmacology and Therapeutics (in Japanese), Vol.15, pp. 67-80, Ed. Irie, M., Joho Kaihatsu Kenkyujo Ltd. Tokyo, Japan
8. Gaworski, C. L., Aranyi, C., Vana, S., Rajendran, N., Abdo, K., Levine, B. S. and Hall III, A. (1991): Prechronic inhalation studies of 2-mercaptobenzimidazole (2-MBI) in F344/N rats. Fundam. Appl. Toxicol., 16, 161-171.
9. Haynes, R. C. and Murard, F. (1985): Thyroid and antithyroid drugs. In The Pharmacological Basis of Therapeutics, (Goodman, A. G., Rall, T. W. and Murard, F., Eds.), 7th ed., pp.1389-1411, Macmillan, New York.
10. Haynes, R. C. (1990): Thyroid and antithyroid drugs. In The Pharmacological Basis of Therapeutics, (Gilman, A. G., Rall, T.W, Nies, A.S. and Taylor, P., Eds.), 8th Edition, pp.1361-1383, Pergamon Press, USA
11. IARC (1974): Ethylenethiourea. IARC Monogr. Eval. Carcinog. Risk 7: 45-52.
12. Janssen, F. W., Young, E. M., Kirkman, S. K., Sharma, R.N. and Ruelius, H. W. (1981): Biotransformation of the immunomodulator, 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo[3,2a]benzimidazole-2-acetic acid, and its relationship to thyroid toxicity. Toxicol. Appl. Pharmacol., 59, 355-363.
13. Kellen, J. A. (1972) : Effect of hypothyroidism on induction of mammary tumors in rats by 7, 12-dimethylbenz(a)anthracene. J. Natl. Cancer Inst., 48, 1901-1904.
14. Levin, S., Semler, D. and Ruben, Z. (1993) : Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol. Pathol., 21, 1-14.
15. Lorke, D. (1983): A new approach to practical acute toxicity testing. Arch. Toxicol., 54, 275-287.
16. Malmfors, T. (1976): Thymus, the forgotten organ in toxicological testing. Appl. Pharmacol., 37, 185.
17. Norford, D. C., Meuten, D. J., Cullen, J. M. and Collins, J.J. (1993): Pituitary and thyroid gland lesions induced by 2-mercaptobenzimidazole (2-MBI) inhalation in male Fischer-344 rats. Toxicol. Pathol., 21, 456-464.
18. Onodera, H., Mitsumori, K., Takahashi, M., Shimo, T., Yasuhara, K., Kitaura, K., Takahashi, M. and Hayashi, Y. (1994): Thyroid proliferative lesions induced by anti-thyroid drugs in rats are not always accompanied by sustained increases in serum TSH. J. Toxicol. Sci., 19, 227-234.
19. Paynter, O. E., Burin, G. J., Jaeger, R. B. and Gregorio, C. A. (1988): Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process. Regul. Toxicol. Pharmacol., 8, 102-119.
20. Searle, C. E., Lawson, A. and Hemmings, A. W. (1950): Antithyroid substances, 1. The mercaptoglyoxalines. Biochem. J., 47, 77-81.
21. Taurog, A. (1976): The mechanism of action of the thioureylene antithyroid drugs. Endocrinology 98, 1031-1046.
22. Visser, T. J., van Overmeeren, E., Fekkes, D., Docter, R. and Hennemann, G. (1979): Inhibition of iodothyronine 5′-deiodinase by thioureylenes: Structure-activity relationship. FEBS Lett., 103, 314-318.
23. Yamano, T., Noda, T., Shimizu, M. and Morita, S. (1995): The adverse effects of oral 2-mercaptobenzimidazole on pregnant rats and their fetuses. Fund. Appl. Toxicol., 25, 218-223.